Dr. Heller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8600 Old Georgetown Rd
Bethesda, MD 20814Phone+1 301-896-3517Fax+1 301-493-4259
Education & Training
- University of MarylandFellowship, Gastroenterology, 1997 - 2000
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1990 - 1993
- University of the WitwatersrandClass of 1989
Certifications & Licensure
- MD State Medical License 1992 - 2026
Clinical Trials
- Immune Response to Hepatitis C Virus Start of enrollment: 2000 Sep 24
- Pegylated Interferon to Treat Chronic Hepatitis D Start of enrollment: 2001 Aug 01
- Lonafarnib for Chronic Hepatitis D Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- Roux limb revision for recalcitrant bile reflux after total gastrectomy.Amber F Gallanis, Cassidy Bowden, Disha Sharma, Gracia Viana Rodriguez, Rachael Lopez
Surgery. 2025-02-15 - The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency.Prabha Chandrasekaran, Máté Krausz, Yu Han, Noriko Mitsuiki, Annemarie Gabrysch
Microbiome. 2025-02-11 - Adolescents and Young Adults with Germline CDH1 Variants and the Risk of Overtreatment.Amber F Gallanis, Cassidy Bowden, Rachael Lopez, Grace-Ann Fasaye, David Lang
Journal of the National Cancer Institute. 2025-01-06
Journal Articles
- Characterization of the Hepatosplenic and Portal Venous Findings in Patients with Proteus SyndromeTheo Heller, MD, American Journal of Medical Genetics Part A
- Rheological Determinants for Simultaneous Staging of Hepatic Fibrosis and Inflammation in Patients with Chronic Liver DiseaseAhmed M Gharib, Theo Heller, NMR in Biomedicine
Press Mentions
- FDA Rejects Full Approval of Liver Disease DrugNovember 12th, 2024
- Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel SaysSeptember 13th, 2024
- FDA Summit on Gene Therapy Risks Proves TimelySeptember 7th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: